Novocure (NASDAQ: NVCR) announced final results from its Phase 3 METIS trial of Tumor Treating Fields therapy for brain metastases ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE